Global Injectable Drug Delivery Market Report 2022-2028 with Key Company Analysis of Pfizer, GSK, Eli Lilly, Baxter and BD and Co - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Injectable Drug Delivery Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.

The global injectable drug delivery market is anticipated to grow at a substantial CAGR of 12.8% during the forecast period

The growth of the global injectable drug delivery market during the forecast period can be attributed to the increasing prevalence of chronic diseases such as diabetes, among others across the globe.

According to the International Diabetes Federation (IDF), in 2021, approximately 537 million adults aged 20-79 years has diabetes globally with 3 in 4 adults with diabetes living in low- and middle-income countries globally. Additionally, the total number of people living with diabetes is anticipated to rise to 643 million by 2030 and 783 million by 2045.

The global injectable drug delivery market is segmented based on the mode of administration, usability, and end-user. Based on the mode of administration, the market is sub-segmented into oral and pulmonary. Based on usability, the market is sub-segmented into reusable and disposable. Based on the end-user, the market is sub-segmented into hospitals & clinics, home care settings, and others. Among these, the oral segment is anticipated to grow during the forecast period due to numerous technological advancements to accelerate the convenience and ease of administration

Geographically, the global injectable drug delivery market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the major share in the market due to the robust healthcare infrastructure as well as the increasing geriatric population in the region, followed by the Asia-Pacific due to rising technological adoption in countries such as India, China, Singapore, and Japan.

Additionally, the growing healthcare system in the region is further driving the growth of the market. For instance, as per the India Brand Equity Foundation (IBEF), the government of India is planning to introduce a credit incentive program worth $ 6.8 billion to boost the country’s healthcare infrastructure.

The major companies serving the global injectable drug delivery market include Becton, Dickinson and Co., Baxter International Inc., Eli Lilly and Co., GlaxoSmithKline PLC, and Pfizer Inc., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, and geographical expansion, to stay competitive in the market.

For instance, in November 2021, Ypsomed launched YpsoMate On, an autoinjector for prefilled syringes with integrated connectivity. The new device also supports the company’s goal to have CO2-neutral production by 2030 and reach net-zero emissions along the entire value creation chain by 2040.

Key Topics Covered:

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis

3.1.1. Becton, Dickinson, and Co.

3.1.1.1. Overview

3.1.1.2. Financial Analysis

3.1.1.3. SWOT Analysis

3.1.1.4. Recent Developments

3.1.2. Baxter International Inc.

3.1.2.1. Overview

3.1.2.2. Financial Analysis

3.1.2.3. SWOT Analysis

3.1.2.4. Recent Developments

3.1.3. Eli Lilly and Co.

3.1.3.1. Overview

3.1.3.2. Financial Analysis

3.1.3.3. SWOT Analysis

3.1.3.4. Recent Developments

3.1.4. GlaxoSmithKlinePLC

3.1.4.1. Overview

3.1.4.2. Financial Analysis

3.1.4.3. SWOT Analysis

3.1.4.4. Recent Developments

3.1.5. Pfizer Inc.

3.1.5.1. Overview

3.1.5.2. Financial Analysis

3.1.5.3. SWOT Analysis

3.1.5.4. Recent Developments

3.2. Key Strategy Analysis

3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

4.1. Global Injectable Drug Delivery Market by Mode of Administration

4.1.1. Oral

4.1.2. Pulmonary

4.2. Global Injectable Drug Delivery Market by Usability

4.2.1. Reusable

4.2.2. Disposable

4.3. Global Injectable Drug Delivery Market by End-User

4.3.1. Hospitals & Clinics

4.3.2. Home Care Settings

4.3.3. Others

5. Regional Analysis

5.1. North America

5.1.1. United States

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain

5.2.5. France

5.2.6. Rest of Europe

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. South Korea

5.3.5. Rest of Asia-Pacific

5.4. Rest of the World

6. Company Profiles

6.1. Alkermes PLC

6.2. Antares Pharma

6.3. Genentech Inc.

6.4. Gerresheimer AG

6.5. Hikma Pharmaceuticals PLC

6.6. Lifelong Meditech Ltd.

6.7. Novartis AG

6.8. Schott AG

6.9. SHL Group

6.10. Terumo Corp.

6.11. Teva Pharmaceutical Industries Ltd.

6.12. Troikaa Pharmaceuticals Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/vpqqvn

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900